Vertex Pharmaceuticals Inc (VRTX)
450.38
-0.85
(-0.19%)
USD |
NASDAQ |
Nov 21, 16:00
450.38
0.00 (0.00%)
After-Hours: 17:18
Vertex Pharmaceuticals Total Return Level: 451.23 for Nov. 20, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 20, 2024 | 451.23 |
November 19, 2024 | 448.01 |
November 18, 2024 | 467.01 |
November 15, 2024 | 465.70 |
November 14, 2024 | 483.96 |
November 13, 2024 | 494.61 |
November 12, 2024 | 490.00 |
November 11, 2024 | 501.72 |
November 08, 2024 | 516.74 |
November 07, 2024 | 502.45 |
November 06, 2024 | 493.64 |
November 05, 2024 | 499.88 |
November 04, 2024 | 472.80 |
November 01, 2024 | 471.12 |
October 31, 2024 | 475.98 |
October 30, 2024 | 475.08 |
October 29, 2024 | 470.36 |
October 28, 2024 | 476.37 |
October 25, 2024 | 477.70 |
October 24, 2024 | 471.91 |
October 23, 2024 | 470.05 |
October 22, 2024 | 474.91 |
October 21, 2024 | 478.09 |
October 18, 2024 | 483.00 |
October 17, 2024 | 498.73 |
Date | Value |
---|---|
October 16, 2024 | 487.25 |
October 15, 2024 | 484.30 |
October 14, 2024 | 484.82 |
October 11, 2024 | 481.71 |
October 10, 2024 | 476.15 |
October 09, 2024 | 467.97 |
October 08, 2024 | 458.94 |
October 07, 2024 | 448.60 |
October 04, 2024 | 455.31 |
October 03, 2024 | 453.55 |
October 02, 2024 | 462.14 |
October 01, 2024 | 469.76 |
September 30, 2024 | 465.08 |
September 27, 2024 | 462.88 |
September 26, 2024 | 463.15 |
September 25, 2024 | 461.76 |
September 24, 2024 | 462.99 |
September 23, 2024 | 460.00 |
September 20, 2024 | 464.92 |
September 19, 2024 | 477.90 |
September 18, 2024 | 474.16 |
September 17, 2024 | 481.26 |
September 16, 2024 | 489.43 |
September 13, 2024 | 485.37 |
September 12, 2024 | 478.65 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
177.01
Minimum
Oct 05 2021
516.74
Maximum
Nov 08 2024
299.15
Average
282.08
Median
Total Return Level Benchmarks
Gilead Sciences Inc | 123.07 |
Eli Lilly and Co | 2179.05 |
Bristol-Myers Squibb Co | 237.72 |
Moderna Inc | 36.94 |
Pfizer Inc | 89.06 |